Home > > > > > Report Detail

United States Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 - 2030

Publisher Name :
Date: 13-Feb-2022
No. of pages: 142

Amid the COVID-19 crisis, the United States market for non-invasive prenatal testing (NIPT) estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 - 2030.

The Prominent Factors that are Expected to Contribute to the Growth of the United States Non-Invasive Prenatal Testing Market During the Forecast Period:


  • increase in incidences of chromosomal aneuploidies among fetus

  • progress of advanced non-invasive prenatal testing products

  • rising adoption regarding non-invasive prenatal testing

  • growing focus on reimbursement for non-invasive prenatal testing

  • increasing preference for non-invasive techniques over invasive methods

  • ACOG guidelines recommend NIPT for all pregnancies regardless of risk


After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States non-invasive prenatal testing (NIPT) market are obtained with maximum precision.

This new 2022 market report provides a holistic analysis of the entire United States non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United States non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2030 covering key market aspects like market value and volume for non-invasive prenatal testing in the United States.

The report also includes the latest insights on comparative test analysis by companies. The following points are covered in the comparative test analysis: technology, fetal fraction, starting week, twin, sex chromosome aneuploidy, gender, deletion/duplication, triploidy, turnaround time, egg donor, accuracy, and many more.

Additionally, this up-to-date report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States non–invasive prenatal testing market.

The report also tracks and analyses competitive developments, including collaboration deals, mergers & acquisitions, venture capital investment, distribution, exclusive and licensing agreements, and partnerships deals.

The report also covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.

This Newest and Comprehensive the United States Non-Invasive Prenatal Testing Market Research Report 2022 Delivers:


  • Comprehensive Research Methodology of the United States Non-Invasive Prenatal Testing Market

  • The report includes a Detailed and Extensive Market Overview with Key Analyst Insights

  • Insights about market determinants that are stimulating the United States Non-Invasive Prenatal Testing Market

  • To Analyse the Historical Growth in the Market Size of the United States Non–Invasive Prenatal Testing Market from 2018 to 2021

  • To Estimate and Forecast the Market Size of the United States Non–Invasive Prenatal Testing Market from 2022 to 2030 and Growth Rate until 2030

  • The Market Size of the United States Average Risk Non–Invasive Prenatal Testing Market with Eight Years Forecast

  • The Market Size of the United States High-Risk Non–Invasive Prenatal Testing Market with Eight Years Forecast

  • Evaluates the Number of NIPT Tests Performed in the United States with Eight Years Forecast

  • Studies the United States Number of Average Risk NIPT Tests Performed with Eight Years Forecast

  • Examines the United States Number of High-Risk NIPT Tests Performed with Eight Years Forecast

  • Assessment of Market Potential and Opportunities for this Innovation-Driven United States Non–Invasive Prenatal Testing Market with Eight Years Forecast

  • Insights into the United States Average and High-Risk Potential NIPT Tests Market with Eight Years Forecast

  • Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends

  • Analyses of the United States Average and High-Risk Potential Number of Tests Performed with Eight Years Forecast

  • Detailed Insights into the Regulatory Framework of the United States Non–Invasive Prenatal Testing Market

  • Features Reimbursement Patterns of the United States Non–Invasive Prenatal Testing Market

  • Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement

  • Extensive Profiles and Recent Developments of 12 Market Players.


The Key Market Players for the United States Non–Invasive Prenatal Testing Market are Listed Below:


  • Illumina, Inc.

  • Natera, Inc.

  • Quest Diagnostics

  • Myriad Genetics, Inc.

  • Centogene

  • GenPath

  • PerkinElmer

  • Yourgene Health

  • Invitae Corporation

  • Agilent Technologies

  • Ariosa Diagnostics (Roche)

  • Laboratory Corporation of America Holdings


Key Questions Answered in this Report:


  • What is the current scenario of the united states non–invasive prenatal testing market?

  • What is the total market size and forecast (until 2030) for the united states non–invasive prenatal testing market?

  • How big is the united states NIPT tests market?

  • Which is the best non-invasive prenatal test?

  • How has the potential market performed so far and how will it perform in the coming years?

  • How many NIPT tests are being performed in the united states during 2018 – 2030?

  • What is the market size of the average risk NIPT tests in the united states?

  • What is the market size of the high-risk NIPT tests in the united states?

  • What are the key marketed NIPT tests available in the united states?

  • What are the major drivers of the united states non–invasive prenatal testing market?

  • What are the major inhibitors of the united states non–invasive prenatal testing market?

  • What is the reimbursement pattern in the united states non–invasive prenatal testing market?

  • What is the regulatory framework in the united states non–invasive prenatal testing market?

  • What are the major deals and agreement happenings in the united states non–invasive prenatal testing market?

  • What companies offer NIPT tests in the united states?

  • Who are the top market players? What are their happenings, current developments, and scenarios?

  • How is the market predicted to develop in the future?

United States Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 - 2030

Table of Contents

1. Executive Summary

2. United States Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 - 2030)
2.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
2.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast

3. United States Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 - 2030)
3.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
3.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast

4. United States Actual Non–Invasive Prenatal Testing Market Size and Forecast (2018 - 2030)
4.1 Average Risk Actual NIPT Test Market Size and Forecast
4.2 High-Risk Actual NIPT Test Market Size and Forecast

5. United States Potential Non–Invasive Prenatal Testing Market Size and Forecast (2018 - 2030)
5.1 Average Risk Potential NIPT Test Market Size and Forecast
5.2 High-Risk Potential NIPT Test Market Size and Forecast

6. United States Non–Invasive Prenatal Testing Market Growth Drivers and Challenges
6.1 Key Market Growth Drivers
6.2 Key Market Challenges

7. Non–Invasive Prenatal Testing Comparative Analysis

8. Reimbursement Environment of the United States Non-Invasive Prenatal Testing

9. Regulation Framework of the United States Non-Invasive Prenatal Testing

10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Mergers and Acquisitions
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals

11. Key Companies Analysis
11.1 Laboratory Corporation of America Holdings
11.1.1 Business Overview
11.1.2 Product Outlook
11.1.3 Key Developments
11.2 Yourgene Health
11.2.1 Business Overview
11.2.2 Product Outlook
11.2.3 Key Developments
11.3 Ariosa Diagnostics (Roche)
11.3.1 Business Overview
11.3.2 Product Outlook
11.3.3 Key Developments
11.4 Illumina,Inc.
11.4.1 Business Overview
11.4.2 Product Outlook
11.4.3 Key Developments
11.5 Natera,Inc.
11.5.1 Business Overview
11.5.2 Product Outlook
11.5.3 Key Developments
11.6 Quest Diagnostics
11.6.1 Business Overview
11.6.2 Product Outlook
11.6.3 Key Developments
11.7 Myriad Genetics,Inc.
11.7.1 Business Overview
11.7.2 Product Outlook
11.7.3 Key Developments
11.8 Centogene
11.8.1 Business Overview
11.8.2 Product Outlook
11.8.3 Key Developments
11.9 Invitae Corporation
11.9.1 Business Overview
11.9.2 Product Outlook
11.9.3 Key Developments
11.10 GenPath
11.10.1 Business Overview
11.10.2 Product Outlook
11.10.3 Key Developments
11.11 PerkinElmer
11.11.1 Business Overview
11.11.2 Product Outlook
11.11.3 Key Developments
11.12 Agilent Technologies
11.12.1 Business Overview
11.12.2 Product Outlook
11.12.3 Key Developments

List of Figures:

Figure 2–1: United States Actual NIPT Test Volume (Thousand),2018 – 2021
Figure 2–2: United States Actual NIPT Test Volume Forecast (Thousand),2022 – 2030
Figure 2–3: United States Average Risk Actual NIPT Test Volume (Thousand),2018 – 2021
Figure 2–4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2022 – 2030
Figure 2–5: United States High-Risk Actual NIPT Test Volume (Thousand),2018 – 2021
Figure 2–6: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2022 – 2030
Figure 3–1: United States Potential NIPT Test Volume (Thousand),2018 – 2021
Figure 3–2: United States Potential NIPT Test Volume Forecast (Thousand),2022 – 2030
Figure 3–3: United States Average Risk Potential NIPT Test Volume (Thousand),2018 – 2021
Figure 3–4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2022 – 2030
Figure 3–5: United States High-Risk Potential NIPT Test Volume (Thousand),2018 – 2021
Figure 3–6: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2022 – 2030
Figure 4–1: United States Actual NIPT Test Market Size (Million US$),2018 – 2021
Figure 4–2: United States Actual NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 4–3: United States Average Risk Actual NIPT Test Market Size (Million US$),2018 – 2021
Figure 4–4: United States Average Risk Actual NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 4–5: United States High-Risk Actual NIPT Test Market Size (Million US$),2018 – 2021
Figure 4–6: United States High-Risk Actual NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 5–1: United States Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5–2: United States Potential NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 5–3: United States Average Risk Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5–4: United States Average Risk Potential NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 5–5: United States High-Risk Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5–6: United States High-Risk Potential NIPT Test Market Size Forecast (Million US$),2022 – 2030

List of Tables:

Table 6–1: Maternal Age at Delivery and Risk of Down Syndrome
Table 7–1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 10–1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 10–2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 10–3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 10–4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 10–5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 10–6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 10–7: Partnership Deals in the Non–Invasive Prenatal Testing Market

  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs